- Home
- About ASF
- What is Autism?
- What We Fund
- Autism Science
- Media Center
- Get Involved
- Contact Us
Cambridge's Seaside at Forefront of new approach to Fragile X
Source:
The Boston Globe
Date Published:
August 23, 2010
Abstract:
The story of Matthew, a 9-year-old with Fragile X Syndrome, is one of the first patients on one of the first medications ever developed specifically to address the causes of an autism-like disorder. And — at least for him — it seems to be working.


